|

Peripheral Blood Stem Cell Transplant Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Masonic Cancer Center, University of Minnesota1

Indications

  • Myelofibrosis1
  • Relapsed Chronic Lymphocytic Leukemia1
  • Relapsed T-Cell Lymphoma1
  • Prolymphocytic Leukemia1
  • Undifferentiated Leukemia1

Minneapolis, Minnesota1 trial

Allo HSCT Using RIC and PTCy for Hematological Diseases

Masonic Cancer Center at University of Minnesota

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.